Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB123667 in Platinum-Resistant Ovarian Cancer (MAESTRA 1)
NCT07023627Phase 2Recruiting
- Sponsor
- Incyte
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of INCB123667 in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Incyte. Started Nov 2025; status: recruiting.
02
Drugs
INCB123667
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT07023627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023627.